Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan

Indian Journal of Human Genetics

Volumn 16, Issue 3, 2010, Pages 138-143

  Al Farra, Helmi Yousif ^a,b  

^a YARMOUK UNIVERSITY   (Jordan)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Jordan; MTR; neural tube defects; polymorphism

Indexed keywords

METHIONINE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JORDAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 78650165958     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.73405     Document Type: Article

References (28)

1. Brody LC, Baker PJ, Chines PS, Musick A, Molloy AM, Swanson DA, et al. Methionine synthase: High-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol Genet Metab 1999;67:324-33.
2. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 1997;272:3628-34.
3. Goulding CW, Postigo D, Matthews RG. Cobalamin-dependent methionine synthase is amodular protein with distinct regions for binding homocysteine, methyltetrahydrofolate, cobalamin, and adenosylmethionine. Biochemistry 1997;36:82-91.
4. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998;95:3059-64.
5. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2002;78: 216-21.
6. Lucock M. Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-38.
7. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
8. Morrison K, Edwards YH, Lynch SA, Burn J, Hol F, Mariman E. Methionine synthase and neural tube defects. J Med Genet 1997;34:958.
9. Wang XL, Duarte N, Cai H, Adachi T, Sim AS, Cranney G, et al. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. Atherosclerosis 1999;146:133-40.
10. Wilson A, Leclerc D, Saberi F, Campeau E, Hwang H, Shane J, et al. Functionally null mutation in patients with the cnlG-variant form of methionine synthase deficiency. Am J Hum Genet 1998;63:153-62.
11. Swanson DA, Liu ML, Baker PJ, Garrett L, Stitzel M, Wu J, et al. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 2001;21:1058-65.
12. Wang XL, Cai H, Cranney G, Wilcken DE. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease. J Cardiovasc Risk 1998;5:289-95.
13. Hyndman ME, Bridge PJ, Warnica JW, Fick G, Parsons HG. Effect of heterozygosity for the methionine synthase 2756 AG mutation on the risk for recurrent cardiovascular events. Am J Cardiol 2000;86:11-44.
14. Morita H, Kurihara H, Sugiyama T, Hamada C, Kurihara Y, Shindo T, et al. Polymorphism of the methionine synthase gene: Association with homocysteine metabolism and lateonset vascular diseases in the Japanese population. Arteriosclerosis Thromb Vasc Biol 1999;19:298-302.
15. D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, et al. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene a case-control study of patients with early-onset thrombotic events. Thromb Haemost 2000;83:563-70.
16. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate-and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001;97:3205-9.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nueleic Acids Res 1988;16:1215.
18. Johanning GL, Wenstrom KD, Tamura T. Changes in frequencies of heterozygous thermolabile 5, 10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects. J Med Genet 2002;39:366-7.
19. Al-Nasser AD. Lecture notes in statistical analysis using SPSS. Jordan: Department of Statistics, Yarmouk University; 2007.
20. Anwar W, Guant JL, Abdelmouttaleb I, Adjalla C, Grard P, Lemoel G, et al. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolatereductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis. Clin Chem Lab Med 2001;39:747-52.
21. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate- dehydrogenase methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects. Am J Hum Genet 2002;71:1207-15.
22. Hol FA, van der Put NM, Geurds MP, Heil SG, Trijbels FJ, Hamel BC, et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD1 (mthylenetetrahydrofolatecyclohdrolase, formyltetrahydrofolate synthase) in patients with neural tube defects. Clin Genet 1998;53:119-25.
23. Silaste ML, Rantala M, Smpi M, Alfthan G, Aro A, Kesniemi YA. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr 2001;131:2643-7.
24. O'Leary VB, Mills JL, Pangilinan F, Kirke PN, Cox C, Conley M, et al. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 2005;85:220-7.
25. van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, et al. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 1997;90:505-10.
26. Daoud A, Al-kaysi F, El-Shanti H, Batieha A, Obeidat A, Al-Sheyyab M. Neural tube defects in northern Jordan. Saudi Med J 1996;17:78-81.
27. Aqrabawi H. Incidence of neural tube defects among neonates at knig Hussein medical center, Jordan. East Mediterr Health J 2005;11:819-23.
28. Masri A. Neural tube defects in Jordan: A hospital based study. J Pediatr Neurol 2006;4:245-9.